Published in J Clin Immunol on November 01, 2000
Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science (1997) 10.35
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
Characterization, sequence determination, and immunogenicity of a 64-kilodalton protein of Mycobacterium bovis BCG expressed in escherichia coli K-12. Infect Immun (1987) 6.00
Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet (1998) 3.45
T cells against a bacterial heat shock protein recognize stressed macrophages. Science (1989) 2.79
Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today (1991) 2.71
Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med (1998) 2.27
Biochemical and antigenic characterization of the Mycobacterium tuberculosis 71kD antigen, a member of the 70kD heat-shock protein family. Mol Microbiol (1989) 1.85
Evidence for an HLA-DR4-associated immune-response gene for Mycobacterium tuberculosis. A clue to the pathogenesis of rheumatoid arthritis? Lancet (1986) 1.43
Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects. J Acquir Immune Defic Syndr (1993) 1.29
Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. J Infect Dis (1999) 1.28
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults. Nat Med (1998) 1.21
Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir. J Infect Dis (1998) 1.18
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J Infect Dis (2000) 1.13
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults. J Infect Dis (1999) 1.13
Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study. AIDS (1998) 1.12
Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection. AIDS (1998) 1.08
Modulation of stress protein (hsp27 and hsp70) expression in CD4+ lymphocytic cells following acute infection with human immunodeficiency virus type-1. Virology (1997) 1.08
Heat shock proteins and the inflammatory response. Ann N Y Acad Sci (1998) 1.08
Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience. AIDS Res Hum Retroviruses (1998) 1.04
CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy. Clin Exp Immunol (1999) 1.00
Abnormal intracellular IL-2 and interferon-gamma (IFN-gamma) production as HIV-1-assocated markers of immune dysfunction. Clin Exp Immunol (1998) 1.00
Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70. Cancer Res (1996) 1.00
Cell-mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection. Clin Exp Immunol (1997) 0.98
Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy. AIDS (1999) 0.96
Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection. J Immunol (1999) 0.93
High frequency of cord blood lymphocytes against mycobacterial 65-kDa heat-shock protein. Eur J Immunol (1992) 0.92
Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.88
A comparison of the responsiveness to four new tuberculins among Indonesian patients with pulmonary tuberculosis and healthy subjects. Eur J Respir Dis (1986) 0.87
Heat shock protein-based therapeutic strategies against human immunodeficiency virus type 1 infection. Infect Dis Obstet Gynecol (1999) 0.84
Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years. AIDS (1998) 0.83
Improved immunotherapy for pulmonary tuberculosis with Mycobacterium vaccae. Tubercle (1990) 0.82
Restoration of normal interleukin-2 production by CD4+ T cells of human immunodeficiency virus-infected patients after 9 months of highly active antiretroviral therapy. J Infect Dis (1999) 0.82
Lack of skin test reactivity to common mycobacterial antigens in human immunodeficiency virus infected individuals with high CD4 counts. Thorax (1996) 0.81
The cell surface marker phenotype of macrophages from HIV-1-infected subjects reflects an IL-10-Enriched and IFN-gamma-deprived donor environment. J Interferon Cytokine Res (1996) 0.79
Natural killer cell reactivity: activation and cytolysis mechanism models, involving heat shock protein, haemopoietic histocompatibility, major histocompatibility complex and complement molecules. Med Hypotheses (1998) 0.77
Psoriasis patients have T-cells with reduced responsiveness to common mycobacterial antigens. FEMS Immunol Med Microbiol (1998) 0.75
Rapid synthesis of oligodeoxyribonucleotides VI. Efficient, mechanised synthesis of heptadecadeoxyribonucleotides by an improved solid phase phosphotriester route. Nucleic Acids Res (1981) 11.77
Are all contraceptive failures unintended pregnancies? Evidence from the 1995 National Survey of Family Growth. Fam Plann Perspect (2000) 8.91
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N Engl J Med (1999) 7.28
Rapid synthesis of oligodeoxyribonucleotides. IV. Improved solid phase synthesis of oligodeoxyribonucleotides through phosphotriester intermediates. Nucleic Acids Res (1980) 7.01
Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med (1992) 5.29
Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci U S A (1989) 5.03
HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell (1990) 4.50
Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology (1986) 3.98
Rapid synthesis of oligodeoxyribonucleotides. VII. Solid phase synthesis of oligodeoxyribonucleotides by a continuous flow phosphotriester method on a kieselguhr-polyamide support. Nucleic Acids Res (1982) 3.95
HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J (1990) 3.92
Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today (1991) 3.79
Changes in trabecular pattern of the upper end of the femur as an index of osteoporosis. J Bone Joint Surg Am (1970) 3.68
Treatment of hepatic hydatid disease with mebedazole: preliminary results in four cases. Br Med J (1977) 3.10
Rapid synthesis of oligodeoxyribonucleotides. V. Further studies in solid phase synthesis of oligodeoxyribonucleotides through phosphotriester intermediates. Nucleic Acids Symp Ser (1980) 2.94
[Immunoenzymologic diagnosis of parasitic diseases. II. Quantitative immunoenzymology]. Lille Med (1976) 2.74
Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J Cell Biol (1993) 2.64
Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci U S A (1994) 2.58
Structural characterization of the human respiratory syncytial virus fusion protein core. Proc Natl Acad Sci U S A (2000) 2.58
Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks. Thorax (1996) 2.54
T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis. Infect Immun (1989) 2.51
Intestinal malrotation in adults. Indian J Gastroenterol (1991) 2.47
Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol (1992) 2.33
Biotransformation of dehydroabietic acid with resting cell suspensions and calcium alginate-immobilized cells of Mortierella isabellina. Appl Environ Microbiol (1985) 2.27
The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.26
A multi-antigen print immunoassay for the development of serological diagnosis of infectious diseases. J Immunol Methods (2000) 2.24
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A (1994) 2.21
Specific IgE antibodies in immune adherence of normal macrophages to Schistosoma mansoni schistosomules. Nature (1975) 2.19
Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs. Proc Natl Acad Sci U S A (1991) 2.19
Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol (1983) 2.17
A new function for platelets: IgE-dependent killing of schistosomes. Nature (1983) 2.11
Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice. Nat Med (2001) 2.08
A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats. Neuropsychopharmacology (2008) 2.07
Hydrogen peroxide fogging in an overcrowded tertiary care referral centre: some practical queries. J Hosp Infect (2005) 2.06
Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03
Intracuff pressure comparison between ProSeal(®) and Supreme(®) laryngeal mask airways. Anaesthesia (2013) 2.02
Use of a peripheral nerve stimulator for predicting caudal epidural analgesia. Anaesthesia (2000) 2.02
Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med (1994) 2.01
Uranium concentration in groundwater in Hisar city, India. Int J Occup Environ Med (2014) 1.99
In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms. Antimicrob Agents Chemother (1996) 1.96
High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature (1994) 1.95
Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. Infect Immun (1997) 1.95
Ligand binding was acquired during evolution of nuclear receptors. Proc Natl Acad Sci U S A (1997) 1.94
Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med (1992) 1.88
Role of IgE receptors in effector function of human eosinophils. J Immunol (1984) 1.87
An electronically collimated gamma camera for single photon emission computed tomography. Part I: Theoretical considerations and design criteria. Med Phys (1983) 1.86
Quality parameters of mango and potential of non-destructive techniques for their measurement - a review. J Food Sci Technol (2010) 1.85
Production of selenomethionine-labelled proteins using simplified culture conditions and generally applicable host/vector systems. Appl Microbiol Biotechnol (2001) 1.83
Subdivision of daughter strains of bacille Calmette-Guérin (BCG) according to secreted protein patterns. J Gen Microbiol (1986) 1.79
Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med (2001) 1.79
Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J Immunol (1997) 1.76
A double-blind placebo-controlled study on prophylactic use of cisapride on feed intolerance and gastric emptying in preterm neonates. Indian Pediatr (2000) 1.74
Price of prostatectomy. Br Med J (1974) 1.74
The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis: a new family of fibronectin-binding proteins? Microbiology (1999) 1.73
Molecular crosstalk in host-parasite relationships: schistosome- and leech-host interactions. Parasitol Today (2000) 1.73
Salience of visual parts. Cognition (1997) 1.73
The role of feedback in the process of health behavior change. Am J Health Behav (2001) 1.72
Poncet's disease: tuberculous rheumatism. Rev Infect Dis (1989) 1.71
IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet (1988) 1.70
Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol (1997) 1.69
Bone-seeking radionuclides: an in vivo study of factors affecting skeletal uptake. Radiology (1974) 1.69
A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression. J Mol Biol (1994) 1.67
Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. Eur J Clin Invest (2001) 1.66
Massively parallel sequencing of the mouse exome to accurately identify rare, induced mutations: an immediate source for thousands of new mouse models. Open Biol (2012) 1.65
Bilateral rhegmatogenous retinal detachment secondary to retinal dialyses associated with multiple retinal breaks. Eye (Lond) (2004) 1.64
Serodiagnosis of toxoplasma infection using a purified parasite protein (P30). Clin Exp Immunol (1985) 1.64
Fc receptors for IgE on human and rat eosinophils. J Immunol (1981) 1.63
Continuities between psychiatric disorders in adolescents and personality disorders in young adults. Am J Psychiatry (1995) 1.61
Evidence for IgE-dependent cytotoxicity by rat eosinophils. J Immunol (1981) 1.61
APOE distribution in world populations with new data from India and the UK. Ann Hum Biol (2006) 1.59
Age specific incidence rate and pathological spectrum of oral cancer in Allahabad. Indian J Med Sci (2003) 1.59
Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis (1995) 1.59
Serodiagnosis of melioidosis in Singapore by the indirect haemagglutination test. Singapore Med J (1991) 1.59
Chemical warfare agents. Environ Toxicol Pharmacol (2008) 1.58
A hydrophobic sequence motif common to N-hydroxylating enzymes. Trends Biochem Sci (1998) 1.57
Genetic diversity in European and Mediterranean faba bean germ plasm revealed by RAPD markers. Theor Appl Genet (1995) 1.55
Uterine artery embolization: the role in obstetrics and gynecology. Clin Imaging (2001) 1.53
Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J Immunol (1999) 1.53
Impact of education and training on neonatal resuscitation practices in 14 teaching hospitals in India. Ann Trop Paediatr (2001) 1.53
Raised agalactosyl IgG and antimycobacterial humoral immunity in Takayasu's arteritis. J Rheumatol (1994) 1.53
A Study of Frequency-Dependent Selection Observed in the Esterase-6 Locus of DROSOPHILA MELANOGASTER Using a Conditioned Media Method. Genetics (1971) 1.52
The molecular mechanisms of severe typhoid fever. Trends Microbiol (2001) 1.51
A new method of energy prescription to improve weight loss. J Hum Nutr Diet (2007) 1.51
Macular hole surgery without prone positioning. Eye (Lond) (2006) 1.50
Effect of single amino acid changes in the region of the adenylylation site of T4 RNA ligase. Biochemistry (1987) 1.50
Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. Rheumatology (Oxford) (2008) 1.49
Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with the NF-kappaB pathway. Eur J Immunol (1999) 1.49
Molecular cloning of a protective antigen of schistosomes. Nature (1987) 1.49
Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scand J Immunol (1989) 1.49
Transitional cell carcinoma of the renal pelvis and ureter. Br J Urol (1989) 1.49
Novel mechanisms of estrogen action in the brain: new players in an old story. Front Neuroendocrinol (1999) 1.48
Interaction between IgE complexes and macrophages in the rat: a new mechanism of macrophage activation. Eur J Immunol (1977) 1.48
Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J Bacteriol (1995) 1.48
Quantitative determination of specific IgE antibodies to Echinococcus granulosus and IgE levels in sera from patients with hydatid disease. Immunology (1975) 1.47
Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis. Scand J Immunol (1998) 1.47
CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity (2001) 1.47
Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol (1991) 1.46
Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng (2001) 1.46
Systemic oxygen uptake during hypothermic cardiopulmonary bypass. Effects of flow rate, flow character, and arterial pH. J Thorac Cardiovasc Surg (1989) 1.46